Literature DB >> 2275886

New concepts affecting the use of antiarrhythmic agents.

R L Woosley1.   

Abstract

Three underappreciated concepts having an important impact on the use of antiarrhythmic agents having Class I activity are discussed. These are stereochemical influences on antiarrhythmic action, the modulated receptor theory, and pharmacogenetics. The stereoisomers of some antiarrhythmic agents behave differently in terms of their potency, disposition, and antiarrhythmic action. For example, the enantiomers of both tocainide and mexiletine are cleared at different rates, and those of disopyramide have opposite effects on repolarization. The modulated receptor theory suggests that the affinity of antiarrhythmic drugs to bind to a specific receptor on or near the sodium channel depends on whether the sodium channel is open, resting, or inactivated. Study of the interaction between the state of the sodium channel and the differing actions of the antiarrhythmic agents have provided evidence for synergistic drug combinations. Pharmacogenetics relates to the differences observed in drug metabolism among individuals, which can result in variations of two- to fourfold in clearance and plasma concentration in some cases. There is still much to learn about Class I antiarrhythmic agents. These concepts should lead to a better understanding of their actions and increase their utility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275886     DOI: 10.1007/bf00357026

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  15 in total

1.  Co-inheritance of the polymorphic metabolism of encainide and debrisoquin.

Authors:  R L Woosley; D M Roden; G H Dai; T Wang; D Altenbern; J Oates; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

2.  Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.

Authors:  E G Whitford; B McGovern; M H Schoenfeld; H Garan; J B Newell; M McElroy; J N Ruskin
Journal:  Am Heart J       Date:  1988-02       Impact factor: 4.749

3.  Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.

Authors:  H J Duff; D Roden; R K Primm; J A Oates; R L Woosley
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

4.  Effects of the combination of quinidine and lidocaine on the upstroke velocity of the cardiac action potential.

Authors:  J W Moyer; L M Hondeghem
Journal:  Proc West Pharmacol Soc       Date:  1980

5.  Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.

Authors:  M Eichelbaum; G Mikus; B Vogelgesang
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

6.  Oxidation of quinidine by human liver cytochrome P-450.

Authors:  F P Guengerich; D Müller-Enoch; I A Blair
Journal:  Mol Pharmacol       Date:  1986-09       Impact factor: 4.436

7.  Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.

Authors:  L A Siddoway; K A Thompson; C B McAllister; T Wang; G R Wilkinson; D M Roden; R L Woosley
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

8.  Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation.

Authors:  A C Uprichard; J D Allen; D W Harron
Journal:  J Cardiovasc Pharmacol       Date:  1988-02       Impact factor: 3.105

9.  Stereospecific interaction of tocainide with the cardiac sodium channel.

Authors:  R S Sheldon; N J Cannon; A S Nies; H J Duff
Journal:  Mol Pharmacol       Date:  1988-03       Impact factor: 4.436

10.  Polymorphism of human cytochrome P-450.

Authors:  F P Guengerich; D R Umbenhauer; P F Churchill; P H Beaune; R Böcker; R G Knodell; M V Martin; R S Lloyd
Journal:  Xenobiotica       Date:  1987-03       Impact factor: 1.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.